BioLife Solutions, Inc. develops, manufactures, and markets patented tissue hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs in the United States. Its products are serum-free and protein-free solutions, which are formulated to reduce preservation-induced, and delayed-onset cell damage and death. The company offers HypoThermosol FRS, a hypothermic storage and shipping media product to mitigate temperature-induced molecular cell stress responses that occur during chilling and re-warming of biologics, intermediate products, and final cell products intended for research and clinical applications; and CryoStor cryopreservation freeze media products to mitigate temperature-induced molecular cell stress responses during freezing and thawing. It also provides BloodStor freeze media products, such as BloodStor 55-5 and BloodStor 100 for cryopreservation of stem and other cells isolated from umbilical cord and peripheral blood, and bone marrow; and cell thawing media, which offers Dextran and saline for washing cryopreserved cells and tissues to dilute or remove cryoprotectants. In addition, the company provides custom product formulation and packaging services; and contract aseptic manufacturing formulation, filling, and finishing services for liquid media products. It markets its products to the regenerative medicine, bio-banking, and drug discovery markets, including hospital-based stem cell transplant centers, pharmaceutical companies, cord blood and adult stem cell banks, and hair transplant centers, as well as suppliers of cells to the drug discovery, toxicology testing, and diagnostic markets. The company markets and sells its products directly using its sales force, as well as through biolifesolutions.com; and through various regional distributors. BioLife Solutions, Inc. was founded in 1987 and is headquartered in Bothell, Washington.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:BLFS
CUSIPN/A
Phone425-402-1400
Debt
Debt-to-Equity RatioN/A
Current Ratio7.82
Quick Ratio6.42
Price-To-Earnings
Trailing P/E Ratio-41.14
Forward P/E Ratio-226.00
P/E GrowthN/A
Sales & Book Value
Annual Sales$11.02 million
Price / Sales11.61
Cash FlowN/A
Price / CashN/A
Book Value$0.74 per share
Price / Book12.22
Profitability
EPS (Most Recent Fiscal Year)($0.21)
Net Income$-2,510,000.00
Net Margins-13.17%
Return on Equity-18.99%
Return on Assets-15.72%
Miscellaneous
Employees40
Outstanding Shares14,150,000
